Picton Mahoney Asset Management’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
DTC
Picton Mahoney Asset Management's GH Position: Q2 2026 in Review
Picton Mahoney Asset Management reduced its Guardant Health (GH) stake by 23% in Q2 2026, selling an estimated $6.32M and leaving 191,876 shares worth $28.8M. The position accounts for 0.21% of the portfolio, ranked #88.
Picton Mahoney Asset Management first reported a position in GH in Q1 2021 and has held it in 6 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Picton Mahoney Asset Management held 191,876 shares of Guardant Health worth $28.8M as of Q2 2026.
- Picton Mahoney Asset Management sold 58,115 Guardant Health shares in Q2 2026, an estimated $6.32M.
- Guardant Health made up 0.21% of Picton Mahoney Asset Management's portfolio in Q2 2026, its #88 holding.
- Picton Mahoney Asset Management first reported a position in Guardant Health in Q1 2021 and has held it in 6 quarters since.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Picton Mahoney Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.